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Uptake is crucial to reducing breast cancer mortality through screening. This review synthesised all
available evidence on mammography pain as a deterrent to subsequent breast screening. Ten databases
were searched. Studies containing empirical data relating mammography pain to breast screening re-
attendance were included (n ¼ 20). In the most robust studies asking women why they had not re-
attended, 25%e46% cited pain, equivalent to approximately 47,000e87,000 women per year in England.
The most robust evidence for an association between pain experienced at a previous mammogram and
subsequent rates of re-attendance suggests that women who previously experienced pain are more likely
than those who did not to fail to re-attend: RR 1.34 (95% CI: 0.94e1.91). The complexity of the pain
phenomenon and of screening behaviours must be recognised. However, there is sufﬁcient evidence to
conclude that painful mammography contributes to non-re-attendance. Given the importance of cumu-
lative participation, effective pain-reducing interventions in mammography are needed.
 2013 Elsevier Ltd. Open access under CC BY-NC-ND license.Introduction
Mammographic screening continues to provoke intense debate,
with some authors arguing that mortality reductions are small and
the beneﬁts largely outweighed by so-called over-diagnosis.1
However, even the strongest detractors agree that mammo-
graphic screening reduces breast cancer mortality to some degree
in those who attend2 and a comprehensive recent review has
supported the continuation of the breast screening programme in
the UK.3 It has been suggested that uptake is the most important
factor in determining the success of a screening programme.4 In
breast screening, overall participation rates are affected by a wide
range of factors, including psychological and socio-economic.5,6
Repeat participation has been studied less often than initial up-
take but client experience is one of the factors affecting re-atten-
dance.7 Attention to the direct client experience is worthwhile as it
should be readily amenable to intervention.
Perceptions of pain and discomfort in mammography have been
extensively studied but, because of heterogeneity in the literature,
the importance of the problem is still not easily quantiﬁed. A review
of breast screening effectiveness8 unhelpfully indicates that
mammography pain rates range from 6% to 76%. However, ratherhelehan).
Y-NC-ND license.than pursuing a deﬁnitive answer on the frequency of mammog-
raphy pain, a more critical issue to quantify is the effect on
screening behaviour.
Conﬂicting evidence exists concerning the effect of mammog-
raphy pain on re-attendance for breast screening. For example, a
New Zealand study found that in 46% of previous participants who
declined subsequent invitations, the major reasonwas pain,9 while
other authors have detected only a very small or no statistically
signiﬁcant relationship.10,11 We therefore elected to undertake a
systematic review of current evidence for the effect of mammog-
raphy pain on screening re-attendancewith the research questions:
1.What is the range, nature and quality of the current evidence? 2.
How commonly do women choose not to re-attend for breast
screening because of a prior painful mammogram? 3. Are there any
sub-groups of women who are more likely to avoid breast
screening because of mammography pain?Materials and methods
Search strategy
Searches were run in 10 online databases: Medline, Embase,
PsycINFO, CINAHL, ASSIA, Cochrane Database of Systematic Re-
views, Sociological Abstracts, SSCI, SCI, and NHS Cancer Screening
Programmes’ online literature database. The search initially took
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2012. We developed search strings speciﬁc to each database in line
with the following search architecture: 1. screening, mammog-
raphy, 2. pain, discomfort, 3. attendance, re-attendance, 4. 2 OR 3, 5.
1 AND 4, 6. Remove duplicates.
Terms were mapped to existing (subsequently exploded) sub-
ject headings. Free text/keyword searching and truncation were
also used. Table 1 shows an example of the search strings used. No
limits or ﬁlters were applied. Where possible, results were de-
duplicated across databases. Additional publications were sought
by hand-searching the reference lists of found articles and relevant
reviews. In cases where it appeared that authors may have
collected data which could answer our research questions but had
not provided enough detail in the publications to meet our needs
fully, we attempted to contact the authors. We received replies
from two authors. The ﬁrst provided additional data but this did not
result in the study meeting our inclusion criteria. No additional
data were received from the second author but the papers already
met the inclusion criteria.12,13
Screening
All results from the searches were downloaded into a reference
management system and a bibliography of the titles and abstracts
was created. Two authors (PW, SM) independently screened all ti-
tles and abstracts to exclude publications which were clearly not
relevant. Full texts were obtained for studies whose titles and ab-
stracts indicated that all inclusion criteria could potentially be met.
Following detailed screening of the full-text articles, additional
exclusions were made and reasons recorded. Inclusion criteria
were: 1. studies screening mammography, 2. provides data on pain
or discomfort, 3. provides information on re-attendance, 4. pro-
vides quantitative empirical data, 5. provides information enabling
analysis of any link between pain/discomfort and re-attendance.
Publications reporting data collected within randomised
controlled trials and screening pilots were excluded because the
samples were unrepresentative of a general screening population,Table 1
Example of the detailed search strings used e Ovid gateway.
Database: Ovid MEDLINE(R) <1948 to January Week 2 2011>, EMBASE <1980
to 2011 Week 03>, PsycINFO <1967 to January Week 3 2011>
Search strategy: originally run on 26/01/11
1 cancer screening.mp. (54577)
2 breast screening.mp. (3061)
3 mammogra$ screening.mp. (6025)
4 exp Mammography/(53299)
5 MAMMOGRAPHY/or exp DIGITAL
MAMMOGRAPHY/(50494)
6 mammogra$.mp. (60124)
7 exp cancer screening/(38833)
8 1 or 2 or 3 or 4 or 5 or 6 or 7 (106728)
9 exp Pain/or pain.mp. or exp Pain Perception/or
exp Pain Threshold/or exp Pain
Measurement/(1201258)
10 discomfort.mp. (59631)
11 exp PAIN ASSESSMENT/(94659)
12 exp Pain Measurement/(95469)
13 exp pain thresholds/(8713)




18 15 or 16 or 17 (35426)
19 14 or 18 (1271568)
20 8 and 19 (3637)
21 remove duplicates from 20 (2597)including with respect to their motivations to participate in
screening.
Data extraction
Following development and piloting of suitable tools, data were
extracted regarding study design, methodology and methodolog-
ical quality, levels and rates of pain/discomfort, re-attendance rates,
and relationships between pain and re-attendance. Two authors
(PW, SM) shared the data extraction and each checked the other’s
ﬁndings.
Assessment of methodological quality
The included studies were assessed for risk of bias according to
individual elements of quality rather than a summary scale
approach. For the assessment of quantitative studies, the use of
such summary scales is not supported by empirical evidence14 and
is actively discouraged.15 Methodological components assessed
were whether intended or actual re-attendance was measured, and
survey response rate/participation rate. Where applicable, the
following were also assessed: details of the pain or discomfort
assessment tool; consistency of the time-point at which the ques-
tion was posed or the pain measured; quality of statistical analysis;
robustness of ascertaining re-attendance rate. Studies which
ascertained actual re-attendance were taken to be more valid than
those which only ascertained intended re-attendance because the
correlation between the two has been found to be only moderate,16
with more women stating an intention to re-attend than actually
do so.17 A threshold of 60%was imposed to distinguish between low
and high risk of non-response bias, although it is recognised that it
is difﬁcult to judge the actual effect of the response rate on overall
study validity without substantial additional information.18 Infor-
mation regarding the study settings was extracted in order to
assess likelihood of applicability of the ﬁndings to organised breast
screening programmes in Europe.
Results
The ﬂowchart in Fig. 1 shows the numbers of studies identiﬁed,
included, and excluded. Following detailed screening of 295 full
publications, 20 studies were included.9,11e13,17,19e33 Of these, most
were from Europe or North America. Each publication reported a
single study; 19 were peer-reviewed journal articles and one26 was
a published conference abstract.
Among the included studies, we identiﬁed two distinct types of
data e "causation data" and "association data". In the causation
data studies9,24e26,30,31,33 the reports indicate the proportion of
women who experienced pain at a prior mammogram and directly
cited this as a reason for non-re-attendance. The association data
studies11e13,17,19e23,25,27e30,32 report proportions of women who
experienced pain and proportions who re-attended (or intended
to), but did not directly ask non-re-attenders for their reasons. Two
publications25,30 report both causation and association data, thus
the total number of datasets is 22.
Causation data
Seven studies9,24e26,30,31,33 (Table 2) provided causation data
from a total of 5741 women. Five of these9,25,30,31,33 provided data
where actual re-attendance was known, while in two24,26 only
intended re-attendance was known. Studies varied regarding the
time-point when reasons for non-re-attendance were ascertained,
and how they were ascertained. Participant response rates also
varied (range: 32%e79%), as did sample sizes (range: 44e2970).
Fig. 1. Flowchart showing numbers of papers retrieved and included/excluded.
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reason ranged from 11% to 46% across the ﬁve studies. The pro-
portion of women who, after index mammography, stated their
intention not to re-attend in future because of pain was 2.7% in one
study24 and 17.5% in the other.26
Association data
Of the 15 studies providing data identifying the association
between pain at index mammography and re-attendance rates atTable 2
Causation data studies.
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Mullai26 (U.S.A.) 2009 Intended Unclear Widely vsubsequent mammographic screening, 10 studies reported data
where actual re-attendance was known12,13,17,21,23,25,27,29,30,32 and 5
studies where only intended re-attendance was known.11,19,20,22,28
Seven of the ten studies where actual re-attendance was known
provided data allowing risk ratios (RR) to be calcu-
lated17,21,23,25,27,29,32 (Table 3). Of the seven, ﬁve studies23,25,27,29,32
provided data where the categorical presence or absence of pain
was known and two studies17,21 provided pain datawhich could not
be dichotomised as pain clearly present or absent. In only one25 of
the ﬁve studies was the pain assessment carried out at a consistent
time interval after the index mammogram.
In three studies23,25,27 of the ﬁve where the categorical presence
or absence of pain was known, the ascertainment of re-attendance
was judged to be robust. In these three, the rate of non-re-
attendance in women who had not reported pain at the index
mammogram was 28% (579/2030) whereas the non-re-attendance
rate in those who had reported painwas 35.5% (316/903). However,
the difference was not statistically signiﬁcant (RR 1.34 [95% CI
0.94e1.91]).
When all ﬁve of the studies in which the categorical presence or
absence of pain was known are considered, the proportions of
women not re-attending for subsequent mammography were very
similar between those reporting pain at the index mammogram
(615/2302 [26.7%]) and those who did not report pain (718/2748
[26.1%]), RR 1.38 [0.94, 2.02]; Z ¼ 1.65; p ¼ 0.10). A random effects
model was used because signiﬁcant heterogeneity was detected:
Tau2 ¼ 0.16; Chi2 ¼ 40.09, df ¼ 4 ((P < 0.00001); I2 ¼ 90%). A
sensitivity analysis was performed regarding the reliability of
methods used to ascertain actual re-attendance, however, signiﬁ-
cant statistical heterogeneity remained, as did the non-signiﬁcance
of differences between groups.
The remaining three association studies reporting actual re-
attendance12,13,30 examined differences between mean pain scores
experienced at previous mammography in women who either re-
attended or did not re-attend for subsequent mammography. The
ﬁrst of the three12 found that non-re-attenders reported experi-
encing more pain at their previous mammography than attenders
(F [1899] ¼ 14, p ¼ 0.001). The second study’s ﬁndings indicated
that mean pain scores were statistically signiﬁcantly higher in non-
re-attenders (n ¼ 2221 mean pain score ¼ 1.9) than re-attenders
(n ¼ 112 mean pain score ¼ 1.8) [p < 0.05].13 In the third study30
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Table 3
Association data studies: risk ratios of non-re-attendance in women who experienced pain at the index mammogram compared to women who did not.
Painful Not painful RR [95% CI]
Events (%) n Events (%) n
Pain dichotomised as present or absent
Studies with reliable method of ascertaining re-attendance
Orton27 1991 41 (21.9%) 187 80 (15.0%) 532 1.46 [1.04, 2.04]
Marshall25 1994 105 (46.9%) 224 24 (26.4%) 91 1.78 [1.23, 2.57]
Edwards23 2011 170 (34.6%) 492 475 (33.8%) 1407 1.02 [0.89, 1.18]
Sub total 316 (35.5%) 903 579 (28.5%) 2030 1.34 [0.94, 1.91]
Studies with unreliable method of ascertaining re-attendance
Peipins29 2006 156 (16.4%) 952 124 (21.8%) 568 0.75 [0.61, 0.93]
Tsai32 2011 143 (32.0%) 447 15 (10.0%) 150 3.20 [1.94, 5.27]
Sub total 299 (21.4%) 1399 139 (19.4%) 718 1.52 [0.37, 6.30]
Total 615 (26.7%) 2302 718 (26.1%) 2748 1.38 [0.94, 2.02]
Pain dichotomised as none/some/possible or substantial/deﬁnite
Hofvind17 2003 2 (5.9%) 34 16 (8.6%) 185 0.68 [0.16, 2.82]
Conlon21 1998 20 (17.4%) 115 35 (20.0%) 175 0.87 [0.53, 1.43]
P. Whelehan et al. / The Breast 22 (2013) 389e394392non-re-attenders (4.9 [SD¼ 2.0]) than re-attenders (4.8 [SD¼ 1.9]):
t ¼ 0.1; df 773 but the method of assessing pain in this study was
wayward.
The ﬁve association data studies which reported only intention
whether to re-attend for subsequent breast screening11,19,20,22,28 are
a particularly methodologically heterogeneous group. Three
studies19,20,22 detected no clear or statistically signiﬁcant associa-
tion. One study11 stated a negative correlation between pain and
the intention to re-participate but it is unclear exactly how the
correlation was determined. The remaining study28 reported an
odds ratio of 0.61 (95% CI: 0.38e0.98) for re-attendance in the
presence of prior pain.
Discussion
Despite current controversies about the magnitude of the breast
cancer mortality reductions attributable to mammographic
screening,3,34 it is indisputable that population mortality re-
ductions are inversely related to screening participation rates.
While women’s motivations/barriers to participation are complex,
decisions whether to re-attend are likely to be inﬂuenced by prior
experience of the screening episode. Given that mammography can
be painful, and that this pain should be amenable to minimisation,
it was important to establish whether it is actually a substantial
deterrent to screening re-attendance or not.
This is the ﬁrst systematic review to examine speciﬁcally the
relationship between pain at mammography and rates of re-
attendance for breast cancer screening. The many important dif-
ferences in the design and conduct of studies on this topic are likely
to account for a large proportion of the variance in quantitative
ﬁndings. Although synthesising the results of such a diverse group
of studies is challenging, the review has produced ﬁrm conclusions.
If the most robust data derive from studies in which participants
speciﬁcally attributed their actual non-re-attendance to pain, and
inwhich response rates were high, then three studies in this review
meet those criteria.9,25,30 In these studies, the proportion of non-re-
attendance accounted for by priormammography pain ranged from
25% to 46%. The sample sizes were small in all three studies, with a
combined sample size of 261. Transposing the two UK studies’
ﬁgures of 25%30 and 41%25 on to the English NHSBSP 2010/11 ﬁgure
for non-attendance following a previous screen within the last ﬁve
years (188,715)35 would mean that between 47,000 and 77,000
women had chosen not to re-attend in that year because of prior
mammography pain. This is an important ﬁnding in the context of
cumulative participation rates being increasingly recognised as animportant performance indicator in screening.36 It is possible that
somewomenwhowithdraw from government-backed population-
based screening programmes may seek mammography in the fee-
paying sector instead but we have found no evidence of this.
The most robust evidence derived from studies which indicate
purely an association between prior mammography pain and non-
re-attendance23,25,27 suggests that a higher proportion of women
reporting pain at mammography will choose not to re-attend for
future breast screening (35%) than of those not reporting pain
(28%), although the difference is not statistically signiﬁcant (RR 1.34
[95% CI 0.94e1.91]; Z ¼ 1.62 [p ¼ 0.11]).
Sample and population characteristics, such as psychosocial and
socio-demographic factors, could be expected to affect re-
attendance for mammography. Although some authors have
considered breast screening attendance in various subgroups of
women, e.g. different ethnicities or age groups,37e39 only a single
study meeting our inclusion criteria33 addressed differences be-
tween subgroups in the effect of pain on re-attendance. This study,
set in the U.S.A., found that a slightly larger proportion of women
with physical disabilities gave pain as a reason for non-re-
attendance than those without a physical disability (11.7% versus
8.5%), although the difference was not statistically signiﬁcant and
the study suffered from a very low survey response rate (32%).
The extent to which painful mammography inﬂuences subse-
quent screening behaviour is undoubtedly Dependent on phe-
nomena beyond simply the presence or absence and the level of
pain experienced. For example, the same speciﬁed and scientiﬁcally
measured pain level may affect behaviour in one woman and not in
another. Interactions with other factors, such as strength of un-
derlying screening motivation, practical barriers to screening
attendance, and aspects of the screening experience other than
pain may account for variable thresholds for behaviour to be
affected by pain. There is some evidence that pain in mammog-
raphy may diminish feelings of self-efﬁcacy11 and thus act as an
indirect factor in decisions not to re-attend for breast screening.
It is a key principle of screening that the test should be
acceptable to the population. Our research has conﬁrmed that the
mammography test is unacceptable to important numbers of the
target population. While some types of intervention to encourage
screening participation, such as GP letters of endorsement,40 could
risk impeaching the principles of informed choice, supporting
continued participation through improving the quality of the client
experience does not impinge on such principles. Equally, it is an
area where screening service providers, as distinct from, for
example, health education providers, have a role to play. There is
P. Whelehan et al. / The Breast 22 (2013) 389e394 393currently a dearth of effective interventions to reduce mammog-
raphy pain,41 therefore further research to minimise the pain is
needed. Interventions which have shown the most promise in the
past are patient-controlled compression and the use of cushioning
pads but both run the risk of adverse effects on image quality.41 A
key area of interest is the quality of the communication between
mammography staff and clients, with several publications showing
effects on reported pain.42,43 The complexity of the pain/discomfort
phenomenon, including the possibility that women give pain as a
reason for non-re-attendance even when other factors are at play,
must be recognised. Importantly, we need to improve our under-
standing, through further in-depth investigation, of women’s ex-
periences of mammography and how they might be improved.
There is a lack of evidence regarding differential effects of pain
on re-attendance in particular subgroups of women. However, it is
possible that e.g. socio-economic disadvantages, which are already
associated with reduced participation in screening programmes6
may render women more susceptible to the deterrent effect of
unpleasant test experiences, perhaps because of more fragile feel-
ings of self-efﬁcacy. Therefore, future research aimed at identifying
population subgroups more likely to be deterred by the experience
of an unpleasant breast screening test may be worthwhile, in order
to facilitate development of targeted interventions. In addition,
understanding the client experience merits keen attention in other
screening programmes.Conﬂict of interest
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